Back to Agenda
ON DEMAND - Opportunities and Challenges for ICH E6 (GCP) Renovation
Session Chair(s)
Pamela Tenaerts, MD, MBA
Chief Scientific Officer, Medable, United States
This forum will describe findings and interpretation of a multi-regional survey and in-depth interviews, conducted to inform appropriate renovation of ICH E6 GCP.
Learning Objective : Explain the results of a survey and in-depth interviews exploring issues and concerns related to ICH E6 (GCP); Discuss findings and insights based on results of multi-stakeholder, multi-regional, survey and in-depth interviews; Describe case studies illustrating obstacles in applying GCP to different types of trials and potential solutions.
Speaker(s)
Panelist
M. Khair ElZarrad, PhD, MPH
Global Head of Regulatory Science and Policy , Sanofi, United States
Panelist
Janette Panhuis, BSN, MBA, RN
Consultant, PHRI, Canada
Panelist
Dagmar Goertz
Director GCP Risk Management Lead, Pfizer Pharma Gmbh, Germany
Have an account?